Clinicians’ Perspectives of Twice-Weekly Rivastigmine Patches for Alzheimer’s Disease Treatment in Spain: The VIITAL 2S Study

Administration routes and dosage significantly impact Alzheimer's disease (AD) treatment effectiveness, as compliance in older patients depends on interactions between concomitant treatments, complex dosages, adverse effects, or medication tolerance. This study aims to describe patient and care...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Patient preference and adherence Ročník 19; s. 1105 - 1118
Hlavní autori:	Piñol Ripoll, Gerard, Salas Carrillo, Mario
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	New Zealand Taylor & Francis Ltd 01.01.2025 Dove Dove Medical Press
Predmet:	Alzheimer's disease Caregivers Clinical medicine compliance Dementia Geriatrics Neurology Original Research Patients Physicians rivastigmine spain Statistical analysis Transdermal medication transdermal patch twice-weekly posology Spain twice-weekly posology transdermal patch rivastigmine Alzheimer’s disease compliance Spain
ISSN:	1177-889X, 1177-889X
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!